Precigen (PGEN) Operating Expenses (2012 - 2026)

Precigen (PGEN) has 15 years of Operating Expenses data on file, last reported at $29.2 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 22.18% year-over-year to $29.2 million in Q1 2026; TTM through Mar 2026 was $125.5 million, a 8.67% decrease from a year earlier, with the FY2025 full-year figure at $120.2 million, down 13.5% from the prior year.
• Operating Expenses for Q1 2026 stood at $29.2 million, up from $26.2 million in the prior quarter.
• Over the last five years, Operating Expenses for PGEN reached as high as $61.6 million in Q2 2024 and fell as low as $22.2 million in Q3 2024.
• Historically, Operating Expenses has averaged $29.2 million across 5 years, with a median of $26.2 million in 2025.
• Across the five-year window, Operating Expenses soared 168.96% in 2024 and sank 47.01% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $23.6 million in 2022, then surged by 50.48% to $35.5 million in 2023, then decreased by 16.21% to $29.7 million in 2024, then fell by 11.7% to $26.2 million in 2025, then gained by 11.49% to $29.2 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $29.2 million in Q1 2026, $26.2 million in Q4 2025, and $37.4 million in Q3 2025.